Comparative activity and mechanism of action of three types of bovine antimicrobial peptides against pathogenic Prototheca spp.

Journal of Peptide Science

Volumn 18, Issue 2, 2012, Pages 105-113

  Tomasinsig, Linda ^a   Skerlavaj, Barbara ^a   Scarsini, Michele ^a   Guida, Filomena ^b   Piccinini, Renata ^c   Tossi, Alessandro ^b   Zanetti, Margherita ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Antimicrobial activity; Antimicrobial peptide; Beta defensin; Cathelicidin; Prototheca

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTENECIN 5; BOVINE MYELOID ANTIMICROBIAL PEPTIDE 28; LINGUAL ANTIMICROBIAL PEPTIDE; LIPOSOME; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL PERMEABILIZATION; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; KLEBSIELLA PNEUMONIAE; MASTITIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTOTHECA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS UBERIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CATTLE; CELL MEMBRANE; ENTEROBACTERIACEAE; EOSINOPHIL GRANULE PROTEINS; FEMALE; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PERMEABILITY; PROTEIN STRUCTURE, SECONDARY; PROTEINS; PROTOTHECA; STAPHYLOCOCCUS; STREPTOCOCCUS;

ALGAE; BOS; BOVINAE; PROTOTHECA; PROTOTHECA WICKERHAMII;

EID: 84856402886     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1422     Document Type: Article

References (56)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415(6870): 389-395.
2. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003; 55(1): 27-55.
3. Sass V, Schneider T, Wilmes M, Korner C, Tossi A, Novikova N, Shamova O, Sahl HG. Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect. Immun. 2010; 78(6): 2793-2800.
4. Scocchi M, Tossi A, Gennaro R. Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action. Cell. Mol. Life Sci. 2011; 68(13): 2317-2330.
5. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 2005; 6(6): 551-557.
6. Zanetti M. The role of cathelicidins in the innate host defenses of mammals. Curr. Issues Mol. Biol. 2005; 7(2): 179-196.
7. Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009; 30(3): 131-141.
8. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004; 75(1): 39-48.
9. Steinstraesser L, Koehler T, Jacobsen F, Daigeler A, Goertz O, Langer S, Kesting M, Steinau H, Eriksson E, Hirsch T. Host defense peptides in wound healing. Mol. Med. 2008; 14(7-8): 528-537.
10. Jagielski T, Lagneau PE. Protothecosis. A pseudofungal infection. Journal De Mycologie Medicale 2007; 17(4): 261-270.
11. Lass-Florl C, Mayr A. Human protothecosis. Clin. Microbiol. Rev. 2007; 20(2): 230-242.
12. Jagielski T, Lassa H, Ahrholdt J, Malinowski E, Roesler U. Genotyping of bovine Prototheca mastitis isolates from Poland. Vet. Microbiol. 2011; 149(1-2): 283-287.
13. Osumi T, Kishimoto Y, Kano R, Maruyama H, Onozaki M, Makimura K, Ito T, Matsubara K, Hasegawa A. Prototheca zopfii genotypes isolated from cow barns and bovine mastitis in Japan. Vet. Microbiol. 2008; 131(3-4): 419-423.
14. Tortorano AM, Prigitano A, Dho G, Piccinini R, Dapra V, Viviani MA. In vitro activity of conventional antifungal drugs and natural essences against the yeast-like alga Prototheca. J. Antimicrob. Chemother. 2008; 61(6): 1312-1314.
15. Marques S, Silva E, Carvalheira J, Thompson G. Short communication: In vitro antimicrobial susceptibility of Prototheca wickerhamii and Prototheca zopfii isolated from bovine mastitis. J. Dairy Sci. 2006; 89(11): 4202-4204.
16. Lopes MM, Ribeiro R, Carvalho D, Freitas G. In vitro antimicrobial susceptibility of Prototheca spp. isolated from bovine mastitis in a Portugal dairy herd. Journal De Mycologie Medicale 2008; 18(4): 205-209.
17. Ricchi M, Goretti M, Branda E, Cammi G, Garbarino CA, Turchetti B, Moroni P, Arrigoni N, Buzzini P. Molecular characterization of Prototheca strains isolated from Italian dairy herds. J. Dairy Sci. 2010; 93(10): 4625-4631.
18. Sobukawa H, Kano R, Ito T, Onozaki M, Makimura K, Hasegawa A, Kamata H. In vitro susceptibility of Prototheca zopfii genotypes 1 and 2. Med. Mycol. 2011; 49(2): 222-224.
19. Tomasinsig L, De Conti G, Skerlavaj B, Piccinini R, Mazzilli M, D'Este F, Tossi A, Zanetti M. Broad-spectrum activity against bacterial mastitis pathogens and activation of mammary epithelial cells support a protective role of neutrophil cathelicidins in bovine mastitis. Infect. Immun. 2010; 78(4): 1781-1788.
20. Rieg S, Meier B, Fahnrich E, Huth A, Wagner D, Kern WV, Kalbacher H. Differential activity of innate defense antimicrobial peptides against Nocardia species. BMC Microbiol. 2010; 10: 61.
21. Roosen S, Exner K, Paul S, Schroder JM, Kalm E, Looft C. Bovine beta-defensins: identification and characterization of novel bovine beta-defensin genes and their expression in mammary gland tissue. Mamm. Genome 2004; 15(10): 834-842.
22. Swanson K, Gorodetsky S, Good L, Davis S, Musgrave D, Stelwagen K, Farr V, Molenaar A. Expression of a beta-defensin mRNA, lingual antimicrobial peptide, in bovine mammary epithelial tissue is induced by mastitis. Infect. Immun. 2004; 72(12): 7311-7314.
23. Tomasinsig L, Scocchi M, Di Loreto C, Artico D, Zanetti M. Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J. Leukoc. Biol. 2002; 72(5): 1003-1010.
24. Isobe N, Nakamura J, Nakano H, Yoshimura Y. Existence of functional lingual antimicrobial peptide in bovine milk. J. Dairy Sci. 2009; 92(6): 2691-2695.
25. Tomasinsig L, Zanetti M. The cathelicidins-structure, function and evolution. Curr. Protein Pept. Sci. 2005; 6(1): 23-34.
26. Luenser K, Ludwig A. Variability and evolution of bovine beta-defensin genes. Genes Immun. 2005; 6(2): 115-122.
27. Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J. Biol. Chem. 1996; 271(45): 28375-28381.
28. Raj PA, Edgerton M. Functional domain and poly-L-proline II conformation for candidacidal activity of bactenecin 5. FEBS Lett. 1995; 368(3): 526-530.
29. Tokunaga Y, Niidome T, Hatakeyama T, Aoyagi H. Antibacterial activity of bactenecin 5 fragments and their interaction with phospholipid membranes. J. Pept. Sci. 2001; 7(6): 297-304.
30. Tomasinsig L, Skerlavaj B, Papo N, Giabbai B, Shai Y, Zanetti M. Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J. Biol. Chem. 2006; 281(1): 383-391.
31. Morgera F, Pacor S, Creatti L, Antcheva N, Vaccari L, Tossi A. Effects on APC antigen presenting cells of short-term interaction with the human host defense peptide beta-defensin 2. Biochem. J. 2011; 436(3): 537-546.
32. Boniotto M, Antcheva N, Zelezetsky I, Tossi A, Palumbo V, Verga Falzacappa MV, Sgubin S, Braida L, Amoroso A, Crovella S. A study of host defence peptide beta-defensin 3 in primates. Biochem. J. 2003; 374(Pt 3): 707-714.
33. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 1967; 6(7): 1948-1954.
34. Benincasa M, Skerlavaj B, Gennaro R, Pellegrini A, Zanetti M. In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides 2003; 24(11): 1723-1731.
35. Waddell WJ. A simple ultraviolet spectrophotometric method for the determination of protein. J. Lab. Clin. Med. 1956; 48(2): 311-314.
36. Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. Human beta-defensins. Cell. Mol. Life Sci. 2006; 63(11): 1294-1313.
37. Tsuji K, Hirohara J, Fukui Y, Fujinami S, Shiozaki Y, Inoue K, Uoi M, Hosokawa H, Asada Y, Toyazaki N. Protothecosis in a patient with systemic lupus erythematosus. Intern. Med. 1993; 32(7): 540-542.
38. Zavizion B, van Duffelen M, Schaeffer W, Politis I. Establishment and characterization of a bovine mammary epithelial cell line with unique properties. In Vitro Cell. Dev. Biol. Anim. 1996; 32(3): 138-148.
39. Chen YH, Yang JT, Chau KH. Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 1974; 13(16): 3350-3359.
40. Wagschal K, Tripet B, Lavigne P, Mant C, Hodges RS. The role of position a in determining the stability and oligomerization state of alpha-helical coiled coils: 20 amino acid stability coefficients in the hydrophobic core of proteins. Protein Sci. 1999; 8(11): 2312-2329.
41. Morgera F, Antcheva N, Pacor S, Quaroni L, Berti F, Vaccari L, Tossi A. Structuring and interactions of human beta-defensins 2 and 3 with model membranes. J. Pept. Sci. 2008; 14(4): 518-523.
42. Findlay B, Zhanel GG, Schweizer F. Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob. Agents Chemother. 2010; 54(10): 4049-4058.
43. Zanetti M, Gennaro R, Skerlavaj B, Tomasinsig L, Circo R. Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr. Pharm. Des. 2002; 8(9): 779-793.
44. Garcia-Montoya IA, Cendon TS, Arevalo-Gallegos S, Rascon-Cruz Q. Lactoferrin a multiple bioactive protein: an overview. Biochim. Biophys. Acta 2011; doi: 10.1016/j.bbagen.2011.06.018.
45. Kawai K, Shimazaki K, Higuchi H, Nagahata H. Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils. Zoonoses Public Health 2007; 54(3-4): 160-164.
46. Gennaro R, Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 2000; 55(1): 31-49.
47. Benincasa M, Scocchi M, Pacor S, Tossi A, Nobili D, Basaglia G, Busetti M, Gennaro R. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother. 2006; 58(5): 950-959.
48. Sud IJ, Feingold DS. Lipid composition and sensitivity of Prototheca wickerhamii to membrane-active antimicrobial agents. Antimicrob. Agents Chemother. 1979; 16(4): 486-490.
49. van der Weerden NL, Hancock RE, Anderson MA. Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process. J. Biol. Chem. 2010; 285(48): 37513-37520.
50. Niidome T, Mihara H, Oka M, Hayashi T, Saiki T, Yoshida K, Aoyagi H. Structure and property of model peptides of proline/arginine-rich region in bactenecin 5. J. Pept. Res. 1998; 51(5): 337-345.
51. Cabiaux V, Agerberth B, Johansson J, Homble F, Goormaghtigh E, Ruysschaert JM. Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide. Eur. J. Biochem. 1994; 224(3): 1019-1027.
52. Schmidt NW, Mishra A, Lai GH, Davis M, Sanders LK, Tran D, Garcia A, Tai KP, McCray PB, Ouellette AJ, Selsted ME, Wong GC. Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J. Am. Chem. Soc. 2011; 133(17): 6720-6727.
53. Vylkova S, Nayyar N, Li W, Edgerton M. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob. Agents Chemother. 2007; 51(1): 154-161.
54. Sadler K, Eom KD, Yang JL, Dimitrova Y, Tam JP. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 2002; 41(48): 14150-14157.
55. Podda E, Benincasa M, Pacor S, Micali F, Mattiuzzo M, Gennaro R, Scocchi M. Dual mode of action of Bac7, a proline-rich antibacterial peptide. Biochim. Biophys. Acta 2006; 1760(11): 1732-1740.
56. Vylkova S, Li XS, Berner JC, Edgerton M. Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob. Agents Chemother. 2006; 50(1): 324-331.